The Lancet Regional Health Europe in conversation with

In this episode, Deputy Editor Ivana Nedic is joined by Dr Emiliano Calvo to discuss the rapidly evolving landscape of systemic cancer therapies.

Ahead of the upcoming Series in The Lancet Regional Health – Europe, they explore its four key pillars: next-generation antibody-based therapies, antibody-drug conjugates, oncolytic viruses and cancer vaccines, and emerging cell therapies for solid tumours.

The conversation examines the scientific advances driving these approaches, the challenges of toxicity management and equitable access across Europe, and how these innovative modalities may be sequenced and combined in the years ahead to reshape cancer care.

Join Senior Editor Stephanie Becker in an insightful conversation with Santiago Madero as they explore the evolving perspectives on psychedelic treatments, the latest developments in regulatory frameworks, and advances in psychedelic research. 
This episode delves into the complex debates surrounding the therapeutic potential and experiential aspects of psychedelic treatments, highlighting the challenges and opportunities for their safe and effective implementation and regulation.
Click here to read the full article: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00329-1/fulltext

In this anniversary episode, Editor-in-Chief Pooja Jha is joined by Deputy Editor Ivana Nedic and Senior Editor Stephanie Becker to mark five years of The Lancet Regional Health – Europe. Together, they reflect on key milestones from the journal’s first five years, look ahead to priorities for 2026, including new Series and collaborations, and discuss highlights from the January issue.

Tune in for a conversation on how the journal has evolved, what lies ahead for regional health research in Europe, and the editorial thinking shaping the year to come.
The lancet Regional Health – Europe

What are the risks of a future surge in variant Creutzfeldt-Jakob disease cases? 
Join Senior Editor Stephanie Becker as she sits down with Professor Simon Mead to discuss the history of the bovine spongiform encephalopathy epidemic, what updated estimates for future vCJD cases mean for public health policy, and advances in biomarkers and treatments.
Click here to read the full article: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00294-7/fulltext

Alan Fraser and Stefan James talk to Acting Deputy Editor Heather Brown about the evidence needed for regulatory approval of high-risk medical devices, such as stents, valves, pacemakers, and orthopaedic implants. The CORE-MD project makes recommendations for what evidence should be needed and calls for greater transparency and predictability.
Click here to read the full article: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00252-2/fulltext